PIKTOR is designed to inhibit multiple points in a cancer-driving pathway, with topline data expected by year-end. Faeth Therapeutics (Nasdaq: FTH) has received FDA Fast…
August 17, 2026
July 20, 2026
Women’s Oncology Is Entering Its Next Growth Phase as Investment Moves Beyond Breast Cancer
A new PwC report projects the women’s oncology market could approach $110 billion by 2030. Public companies are already advancing innovation across diagnostics, targeted therapies…